
Mycophenolate sodium (360mg)
Active composition
Mycophenolate Sodium inhibits inosine monophosphate dehydrogenase, reducing lymphocyte proliferation and immune response.
Medical applications
Mytrans-S 360 Tablet DR is a pharmaceutical formulation containing Mycophenolate sodium 360mg as the active ingredient. This medication is primarily indicated for the prophylaxis of organ rejection in patients following allogeneic transplantation. Mycophenolate sodium works by inhibiting lymphocyte proliferation, thereby suppressing the immune response and reducing the risk of graft rejection. The extended-release tablets are designed to provide a controlled release of the drug, improving patient compliance and potentially reducing adverse effects associated with higher peak serum concentrations. It is essential to follow the prescribed dosage regimen and monitor blood counts regularly while using Mytrans-S 360 Tablet DR. Consult with a healthcare provider for further guidance on its safe and effective use.
Phthalide Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nutraferon Mytrans-S 360 Tablet DR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nutraferon Mytrans-S 360 Tablet DR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nutraferon Mytrans-S 360 Tablet DR should be used with caution in patients with severe kidney disease. Dose adjustment of Nutraferon Mytrans-S 360 Tablet DR may be needed. Please consult your doctor.
Exercise Caution
Nutraferon Mytrans-S 360 Tablet DR does not usually affect your ability to drive.
Consult Doctor
Nutraferon Mytrans-S 360 Tablet DR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nutraferon Mytrans-S 360 Tablet DR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Mytrans-S 360 Tablet DR

Mycophenolate sodium (360mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Mycophenolate Sodium inhibits inosine monophosphate dehydrogenase, reducing lymphocyte proliferation and immune response.
Medical applications
Mytrans-S 360 Tablet DR is a pharmaceutical formulation containing Mycophenolate sodium 360mg as the active ingredient. This medication is primarily indicated for the prophylaxis of organ rejection in patients following allogeneic transplantation. Mycophenolate sodium works by inhibiting lymphocyte proliferation, thereby suppressing the immune response and reducing the risk of graft rejection. The extended-release tablets are designed to provide a controlled release of the drug, improving patient compliance and potentially reducing adverse effects associated with higher peak serum concentrations. It is essential to follow the prescribed dosage regimen and monitor blood counts regularly while using Mytrans-S 360 Tablet DR. Consult with a healthcare provider for further guidance on its safe and effective use.
Phthalide Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nutraferon Mytrans-S 360 Tablet DR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nutraferon Mytrans-S 360 Tablet DR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nutraferon Mytrans-S 360 Tablet DR should be used with caution in patients with severe kidney disease. Dose adjustment of Nutraferon Mytrans-S 360 Tablet DR may be needed. Please consult your doctor.
Exercise Caution
Nutraferon Mytrans-S 360 Tablet DR does not usually affect your ability to drive.
Consult Doctor
Nutraferon Mytrans-S 360 Tablet DR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nutraferon Mytrans-S 360 Tablet DR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Mytrans-S 360 Tablet DR















